Announcements Trials
Browse Landscape

Status

Withdrawn 2Completed 2Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 566Neoplasms 463Lung Neoplasms 295Colorectal Neoplasms 291Carcinoma, Non-Small-Cell Lung 213Stomach Neoplasms 209Carcinoma, Hepatocellular 201Prostatic Neoplasms 181Pancreatic Neoplasms 151Ovarian Neoplasms 138Uterine Cervical Neoplasms 126Colonic Neoplasms 121Rectal Neoplasms 113Urinary Bladder Neoplasms 96Neoplasm Metastasis 95Esophageal Neoplasms 85Endometrial Neoplasms 83Head and Neck Neoplasms 80Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Leukemia, Myeloid, Acute 78Recurrence 68Brain Neoplasms 68Melanoma 66Disease 64Multiple Myeloma 59Liver Neoplasms 58Lymphoma 57Glioma 56Polycystic Ovary Syndrome 53Squamous Cell Carcinoma of Head and Neck 51

Interventions

olaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Observational × Hyperglycemia × Clear all
NCT05081765 2021-10-18

The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib

Poznan University of Medical Sciences

Unknown
40 enrolled
Gynecologic

Hyperglycemia, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡